机构:[1]Department of Nasopharyngeal Carcinoma, Sun Yat-sen University Cancer Center, Guangzhou, China.[2]Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine.[3]Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangzhou, China.[4]Department of Neurosurgery, The Third Affiliated Hospital of Southern Medical University, Guangzhou, China.[5]The First Affiliated Hospital of Guangzhou University of Traditional Chinese Medicine, Department of Otolaryngology, Guangzhou, China.
The surgical treatment of recurrent nasopharyngeal carcinoma (rNPC) involving the internal carotid artery (ICA) is challenging, as the massive bleeding caused by intraoperative rupture of the ICA is life-threatening. We reported that ICA embolization is an effective pretreatment to avoid fatal bleeding, but some patients cannot tolerate the procedure. We used endovascular vascular protection (ICA stents), vascular sacrifice (bypass grafting) and extravascular vascular protection (transcervical external stent placement) of the ICA to provide alternative options for these patients. METHODOLOGYy: This study enrolled patients with rNPC adjacent to or invading the ICA who were unsuitable for ICA embolization from January 2015 to June 2020. ICA pretreatment combined with endoscopic nasopharyngectomy (ENPG) was performed for the 30 patients. We report the survival outcome and incidence of complications after ICA pretreatment.ICA pretreatment was performed for the 30 enrolled patients, among whom 8 underwent endoscopic-assisted transcervical protection of the parapharyngeal ICA combined with ENPG, 6 underwent bypass grafting, and 16 underwent ICA stent implantation followed by ENPG. After pretreatment, at a median follow-up of 43 months (range, 2-80 months), the 3-year locoregional overall survival (OS), progression-free survival (PFS), locoregional recurrence-free survival (LRRFS), and distant metastasis-free survival (DMFS) were 62.9%, 61.3%, 70.2%, and 71.4%, respectively.ICA pretreatment combined with salvage ENPG enables the feasible and effective resection of rNPC lesions involving the ICA in patients who cannot tolerate ICA embolization. Therefore, this treatment may be an effective method for improving outcomes. Multidisciplinary therapy is needed to reduce operation-related complications.
语种:
外文
PubmedID:
中科院(CAS)分区:
出版当年[2022]版:
大类|1 区医学
小类|2 区耳鼻喉科学
最新[2025]版:
大类|2 区医学
小类|1 区耳鼻喉科学
第一作者:
第一作者机构:[1]Department of Nasopharyngeal Carcinoma, Sun Yat-sen University Cancer Center, Guangzhou, China.[2]Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine.[3]Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangzhou, China.
推荐引用方式(GB/T 7714):
Wu W-B,Zhang X-B,Feng Z-K,et al.Strategies for patients with recurrent nasopharyngeal carcinoma involved internal carotid artery who are intolerant to embolization[J].Rhinology.2023,doi:10.4193/RhinRhin23.130.
APA:
Wu W-B,Zhang X-B,Feng Z-K,Li H-F,Liu Y-P...&Chen M-Y.(2023).Strategies for patients with recurrent nasopharyngeal carcinoma involved internal carotid artery who are intolerant to embolization.Rhinology,,
MLA:
Wu W-B,et al."Strategies for patients with recurrent nasopharyngeal carcinoma involved internal carotid artery who are intolerant to embolization".Rhinology .(2023)